Effect of Chromium on Glucose and Lipid Profiles in Patients with Type 2 Diabetes; A Meta-analysis Review of Randomized Trials | Zendy

Mohammad Abdollahi | Zendy; Amir Farshchi | Zendy; Shekoufeh Nikfar | Zendy; Meysam Seyedifar | Zendy

Open Access

Effect of Chromium on Glucose and Lipid Profiles in Patients with Type 2 Diabetes; A Meta-analysis Review of Randomized Trials

Author(s) -

Mohammad Abdollahi,

Amir Farshchi,

Shekoufeh Nikfar,

Meysam Seyedifar

Publication year - 2013

Publication title -

journal of pharmacy and pharmaceutical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.497

H-Index - 78

ISSN - 1482-1826

DOI - 10.18433/j3g022

Subject(s) - medicine , glycated hemoglobin , triglyceride , lipid profile , placebo , diabetes mellitus , cholesterol , endocrinology , gastroenterology , randomized controlled trial , meta analysis , body mass index , blood sugar , type 2 diabetes , pathology , alternative medicine

Chromium (Cr) as an essential trace element in metabolism of carbohydrate, lipid and protein is currently prescribed to control diabetes mellitus (DM). The objective of this meta-analysis was to compare the effect of Cr versus placebo (Pl) on glucose and lipid profiles in patients with type 2 DM.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research